Editorial policies for clinical trials and the continued changes in medical journalism

JAMA

Volumn 310, Issue 2, 2013, Pages 149-150

  Bauchner, Howard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL STUDY; CONFLICT OF INTEREST; CONTENT ANALYSIS; EDITORIAL; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; MEDICAL LITERATURE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; STUDY DESIGN; CLINICAL TRIAL (TOPIC); METHODOLOGY; PUBLISHING; STATISTICAL ANALYSIS;

CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DATA INTERPRETATION, STATISTICAL; EDITORIAL POLICIES; PUBLISHING; RESEARCH DESIGN;

EID: 84880172193     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.8083     Document Type: Editorial

References (12)

1. DeAngelis D, Drazen JM, Frizell FA, et al. Update on trials registration: is this clinical trial fully registered? a statement from the International Committee of Medical Journal Editors. http://www.icmje.org/update-may05.html. Accessed May 22, 2013.
2. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996;276(8):637-639. (Pubitemid 26278070)
3. Altman DG, Schulz KF, Moher D, et al; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663-694. (Pubitemid 32322245)
4. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726-732.
5. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295(10):1152-1160. (Pubitemid 43352345)
6. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-2604.
7. Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.
8. Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD; CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814-822.
9. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294(1):110-111. (Pubitemid 41002847)
10. DeAngelis CD, Fontanarosa PB. Ensuring integrity in industry-sponsored research: primum non nocere, revisited. JAMA. 2010;303(12):1196-1198.
11. Bauchner H, Fontanarosa PB. Restoring confidence in the pharmaceutical industry. JAMA. 2013;309(6):607-609.
12. Bauchner H, Fontanarosa PB, Golub RM. Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny. JAMA. 2013;309(12):1291-1292.